Canada markets closed

Northwest Biotherapeutics, Inc. (NWBO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.4600-0.0059 (-1.27%)
At close: 03:58PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 549.86M
Enterprise Value 593.30M
Trailing P/E 81.98
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)266.47
Price/Book (mrq)N/A
Enterprise Value/Revenue 307.09
Enterprise Value/EBITDA -10.67

Trading Information

Stock Price History

Beta (5Y Monthly) -0.70
52-Week Change 3-14.55%
S&P500 52-Week Change 322.38%
52 Week High 31.0900
52 Week Low 30.4000
50-Day Moving Average 30.5242
200-Day Moving Average 30.6407

Share Statistics

Avg Vol (3 month) 31.61M
Avg Vol (10 day) 31.35M
Shares Outstanding 51.2B
Implied Shares Outstanding 61.2B
Float 81.11B
% Held by Insiders 19.28%
% Held by Institutions 10.25%
Shares Short (Nov 30, 2016) 414.14M
Short Ratio (Nov 30, 2016) 413.54
Short % of Float (Nov 30, 2016) 415.09%
Short % of Shares Outstanding (Nov 30, 2016) 411.34%
Shares Short (prior month Oct 31, 2016) 413.83M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:16
Last Split Date 3Sept 26, 2012

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-3,402.70%

Management Effectiveness

Return on Assets (ttm)-117.23%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)1.93M
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-25.50%
Gross Profit (ttm)N/A
EBITDA -53.98M
Net Income Avi to Common (ttm)-64.37M
Diluted EPS (ttm)-0.0600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.13M
Total Cash Per Share (mrq)0
Total Debt (mrq)45.56M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.09
Book Value Per Share (mrq)-0.06

Cash Flow Statement

Operating Cash Flow (ttm)-53.64M
Levered Free Cash Flow (ttm)-118.13M